Skip to main content
ELUT logo

ELUT · Elutia Inc.

Track ELUT — free
$0.98 +0.03 (+3.71%) At close · Aug 17
Market Cap
$43.40M
Shares
44.29M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.98 Open$0.95 Day$0.92–1.00 52W close$0.51–2.40 Avg vol 30d79K Short int40K · 0.1% float · 1.0d Short vol33% Last earningsAug 13, 2026 DataOct 2020–Aug 2026 Filing10-Q · Aug 14

Up next

Next earnings call
Nov 9, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Aug 14, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Buy Momentum Neutral Sentiment Bullish Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Buy
      50 / 200-day cross Death cross
      Price vs 200-day avg +4%
      above
      Price vs 50-day avg +4%
      above
      RSI (14) 60
      neutral
      MACD trend Positive
      52-week position 25%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Neutral
      1-month return +5%
      trailing
      6-month return −10%
      trailing
      YTD return +41%
      this year
      Relative strength −23%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) Death cross
      50d $1 › 200d $1 — 200d above 50d
      Institutional flow Accumulating
      +11% holders QoQ · +8 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      0.09% of float · ▼ -7.7% MoM · 1.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      39 holders — near 3-yr high, broad support
      Squeeze score 51
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth −15%
      Y/Y
      Gross margin 54%
      expanding
      EPS growth +147%
      Y/Y
      Free cash flow $-46.7M
      Balance sheet $12.5M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 79%
      annualized · 1-yr
      Max drawdown −79%
      past year
      ATR 7.3%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed May 14, 2026
      Gross margin · at scale at least 80%
      Prior guidance period ended · from the Earnings Call filed Jun 30, 2025
      Revenue rate · year up to $20M

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 3 · 3
      50 / 200-day cross
      Death cross Bearish
      Price vs 200-day avg
      +4% Bullish
      Price vs 50-day avg
      +4% Bullish
      RSI (14)
      60 Neutral
      MACD trend
      Positive Bullish
      52-week position
      25% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) Death cross
      50d $1 › 200d $1 — 200d above 50d
      Institutional flow Accumulating
      +11% holders QoQ · +8 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      0.09% of float · ▼ -7.7% MoM · 1.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      39 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $1 Now $1 · 25% Range high $2
      vs 200-day avg +4% vs 50-day avg +4% 50-day below 200-day death cross

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted EBITDA (Non-GAAP) non-GAAP -$9M Six months ended June 30, 2026
      Adjusted gross profit (Non-GAAP) non-GAAP $3.79M Six months ended June 30, 2026
      Earnings before interest, taxes, depreciation and amortization ("EBITDA") (Non-GAAP) non-GAAP -$14.5M Six months ended June 30, 2026
      Pre-funded warrants outstanding 3.2M Q1 2026
      Shares of Class A common stock outstanding 44.2M Q1 2026
      Total cash and escrow funds $36.5M Q1 2026
      preliminary net sales growth 16% Q4 2025

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Devices — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      ELUT
      Elutia Inc.
      this stock
      $43.40M +40.8% -15.0% 0.1%
      ABT
      Abbott Laboratories
      $193.78B -11.9% +5.7% 31.2 1.3%
      SYK
      Stryker Corp
      $130.11B -5.6% +11.2% 35.2 2.2%
      MDT
      Medtronic plc
      $116.83B -5.7% +8.4% 24.5 1.4%
      BSX
      Boston Scientific Corp
      $74.64B -46.1% +12.5% 20.9 1.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      39
      % held
      32.6%
      Net QoQ
      -804.2K sh
      Top holder
      Nantahala Capital Managem…
      Held Float
      View
      Held by Funds
      Fund positions
      9
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      39.7K
      Days to cover
      1.0d
      Change
      -3.3K sh
      View
      Short Volume
      Short vol %
      33%
      As of
      Aug 17, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      2.8K
      Value
      $2.7K
      As of
      Jul 2, 2026
      View
      Off-Exchange
      Off-exchange %
      42.0%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Net income (FY)
      $53.4M
      EPS diluted
      $0.87
      View
      Filings
      SEC Filings
      Latest
      10-Q
      Filed
      Aug 14, 2026
      This year
      14
      View
      Proposed Sales
      Value
      $6.9K
      Shares
      12.6K
      Filed
      Dec 23, 2025
      View
      Exempt Offerings
      Offering
      $10.5M
      Filed
      Oct 3, 2023
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 13, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      ELUT +19.9% +4.9% -10.5% +13.9% +40.8%
      SPY -0.1% +4.1% +12.4% +3.4% +13.3%
      vs SPY +19.9% +0.8% -22.9% +10.4% +27.5%
      Key facts CIK 1708527 CUSIP 05479K106 13F (30d) 39 filings 38 filers Visit website Investor relations